- Chinese investors seek cryptocurrency education as they adapt and continue to diversify portfolios with bitcoin
- CBD Biotechnology advancing distribution of baijiu
- CIIX planning to spin-off ChineseHempOil.com and CBD Biotechnology subsidiaries in order to focus on cryptocurrency markets
ChineseInvestors.com (OTCQB: CIIX) is an emerging leader in the adoption of cryptocurrencies and blockchain technologies. The company has been leading the way in providing financial information and education for Chinese-speaking investors in the United States and China since 1999. CEO Warren Wang believes that cryptocurrency and blockchain technologies will play a growing role in China’s future economy.
Currently, CIIX broadcasts a daily newscast titled ‘Bitcoin MultiMillionaire’ and operates www.NewCoins168.com, a free Chinese-language bitcoin education site. The company is ready to meet the challenges associated with a growing need for informed reporting and education among the rapidly emerging middle- and upper-class in China, as well as new investors. There are challenges on the horizon with the adoption of blockchain technologies (http://cnw.fm/U5Uci) that CIIX is ready to meet. Chinese investors have managed to adapt to the Beijing ban on cryptocurrency and continue to diversify their portfolios with bitcoin. CIIX is meeting the demand through innovative moves such as the recent addition of a bitcoin ATM in the lobby of its U.S. headquarters in California.
CIIX plans to focus on its new cryptocurrency division and core financial education business. Part of the process is to spin-off its CBD Biotechnology and ChineseHempOil.com subsidiaries, with plans to register them as a separate publicly traded company. This move will allow CIIX to focus more on educational services related to cryptocurrencies and blockchain technologies targeted at the Chinese public. It also offers new opportunities for its subsidiaries.
CBD Biotechnology Co. Ltd. acquired a wholesale alcohol License in China in 2017. The company has expanded its Chinese consumer division to include distribution of baijiu, a popular Chinese grain liquor, by aligning with China GuiZhou HanTai Wine, Inc. CBD Biotechnology has also partnered with Jinri Toutia (translation: Today’s Headlines) to strengthen its marketing platform. Both moves are in hope of strengthening CBD Biotechnology’s brand awareness and sustainable revenue growth.
CIIX’s goal, through subsidiary ChineseHempOil.com, is to become the leading publicly traded company targeting Chinese medicinal marijuana. The creation of an Apple App Store-approved Yelp-style app allows customers to find and recommend nearby locations for medical and recreational cannabis. The company has plans to open a retail store in San Gabriel, California, this year, and it continues to provide nutritional supplements containing CBD through its online platform at www.ChineseCBDoil.com.
For more information, visit the company’s website at www.ChineseInvestors.com
More from CannabisNewsWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information please visit https://www.cbdwire.com